| Edit |   |
| Antigenic Specificity | BID |
| Clone | polyclonal |
| Host Species | Goat |
| Reactive Species | human |
| Isotype | n/a |
| Format | purified |
| Size | 100 ug |
| Concentration | n/a |
| Applications | peptide-ELISA: 1:8000, Western Blot: 0.1-0.3 µg/mL |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | BID Polyclonal Antibody. BID is a death agonist that heterodimerizes with either agonist BAX or antagonist BCL2. Bid is a member of the BCL-2 family of cell death regulators. BID is a mediator of mitochondrial damage induced by caspase-8 (CASP8); CASP8 cleaves this encoded protein, and the COOH-terminal part translocates to mitochondria where it triggers cytochrome c release. BID is also a pro-apoptotic member of the Bcl 2 family. BID usually exists in an inactive form in the cytosolic fraction of living cells and becomes cleaved and activated by caspase 8 in response to TNF alpha or Fas ligand. Once BID is cleaved, the C-terminal 15 kDa fragment of BID (p15) translocates onto mitochondria and is sufficient to trigger cytochrome c release, |
| Immunogen | n/a |
| Other Names | BID; BH3 interacting domain death agonist ; HGNC:1050; MGC15319; MGC42355 ; BH3-interacting domain death agonist; Human BID coding sequence; apoptic d |
| Gene, Accession # | Entrez: 637; Uniprot: P55957 |
| Catalog # | PA1-9016 |
| Price | |
| Order / More Info | BID Antibody from INVITROGEN ANTIBODIES |
| Product Specific References | PubMed: 23943503 |